Insights into Company

ResMed ↗

Part of ResMed.

📍 New Delhi, Delhi, United States Active NYSE RMD CIN U85110DL2007FTC157447 Pharmaceuticals & Healthcare
Search companies

Key Metrics of ResMed

Revenue$4.2B▲ 18.0% YoYFY 2023
Operating income$1.1B▲ 13.2% YoY
Net profit$898M▲ 15.3% YoY
Shareholders' equity$4.5B
Market cap$35.6BRMD · $252.86
Competitors10identified
Open jobs2

About ResMed

Part of ResMed.

Sectors

Pharmaceuticals & HealthcareFormulations & Contract Manufacturing

Company details

Website
resmed.com
Registered office
Cowrks Aerocity 1st Floor, Worldmark 1 Asset Area 11, Aerocity Hospitality District, Igi Airport, New Delhi, In-dl, 110037
Listed
NYSE: RMD

Operational Areas of ResMed

Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing

Company summary

Entity details

CINU85110DL2007FTC157447
LEI code335800I4YLW44UJSPA38
State codeDL
PIN code110037
Current legal nameRESMED
Classification—
Listing statusUnlisted
Registration no.157447
Company age—
PAN—
CountryUnited States
CityNew Delhi
StateDelhi
Current statusActive
Date of incorporation—
Registrar of companies—
Authorised capital—
Paid-up capital—
Employee count—

Compliance

Last AGM date—
Last balance sheet—
Next filing dueAOC-4 for FY 2025-26 · 30 Oct 2026

Industry classification

NIC code85110
Description of main activityHealth and social work
Description of business activityHealth and social work
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing

US market & SEC filings

RMD · NYSE  ·  SEC CIK 0000943819

Last price · 26 Oct 2026 $252.86 −0.08%
Market cap$35.6B
P/E41.5On FY 2023 diluted EPS
Volume1,032,416
SectorHealth CareMedical/Dental Instruments
Country · IPOUnited States

RMD share price

Premium

Annual results (SEC EDGAR)

Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.

Sign in to continue See plans & pricing

Filing compliance

AGM for FY 2025-2630 Sep 2026 Statutory due date passed
AOC-4 for FY 2025-2630 Oct 2026 Statutory due date · 3 days left
MGT-7 for FY 2025-2629 Nov 2026 Statutory due date · 33 days left

Due dates follow the Companies Act: AGM within six months of the year end, AOC-4 within 30 days and MGT-7 within 60 days of the AGM. A filing made but not yet uploaded here shows as pending.

Vendor checks & payment capacity

Sign in with access to company financials to review vendor evidence.

Registered office and contact

Registered officeCOWRKS AEROCITY 1ST FLOOR, WORLDMARK 1 ASSET AREA 11, AEROCITY HOSPITALITY DISTRICT, IGI AIRPORT, NEW DELHI, IN-DL, 110037
GSTIN—
Email—
Websitehttp://www.resmed.com
Members / shareholders—

Directors and key people

Directors are read from the MGT-7 annual return and AOC-4 signatories.

Competitors of ResMed

Competitors10identified
Locations1most in United States

Top competitors by location

CompanyDescriptionDomainFoundedLocation
Eli Lilly and Company Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare lilly.com — United States
Johnson & Johnson Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare jjmt.com.tw — United States
Procter & Gamble Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare pg.com — United States
Merck & Co. Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare merck.com — United States
Amgen Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare amgen.com 1983 United States
Gilead Sciences Part of Gilead Sciences. gilead.com 1992 United States
Abbott Laboratories Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare abbott.com — United States
Pfizer Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare pfizer.com — United States
Bristol-Myers Squibb Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare bms.com — United States
Marriott International Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare marriott.com.cn — United States

Similar companies

Charges (secured borrowings)

0 registered charges. Lenders, amounts and dates are part of the premium plan.

Statutory auditors

Auditors are read from the AOC-4 auditor's report section.

Group companies

Part of ResMed

Business activities and related parties

medicine

Filings

No filings on record yet.